1. Non-canonical Functions of Telomerase Reverse Transcriptase: Emerging Roles and Biological Relevance
    Connor A.H. Thompson et al, 2020, Current Topics in Medicinal Chemistry CrossRef
  2. Modified internucleoside linkages for nuclease-resistant oligonucleotides
    Guillaume Clavé et al, 2021, RSC Chemical Biology CrossRef
  3. Human endometrial epithelial telomerase is important for epithelial proliferation and glandular formation with potential implications in endometriosis
    A.J. Valentijn et al, 2015, Human Reproduction CrossRef
  4. Telomerase and Telomeres Biology in Thyroid Cancer
    Benedetta Donati et al, 2019, International Journal of Molecular Sciences CrossRef
  5. Diminazene or berenil, a classic duplex minor groove binder, binds to G-quadruplexes with low nanomolar dissociation constants and the amidine groups are also critical for G-quadruplex binding
    Jie Zhou et al, 2014, Mol. BioSyst. CrossRef
  6. Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells
    Mark Barszczyk et al, 2014, Acta Neuropathologica CrossRef
  7. Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy
    Adam Eckburg et al, 2020, Cancers CrossRef
  8. Comprehensive analysis of telomerase inhibition by gallotannin
    Nikita Savelyev et al, 2018, Oncotarget CrossRef
  9. The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma
    Yafang Hu et al, 2015, Cancer Biology & Therapy CrossRef
  10. Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor
    Yafang Hu et al, 2014, Cancer Genetics CrossRef
  11. Therapeutic targeting of replicative immortality
    Paul Yaswen et al, 2015, Seminars in Cancer Biology CrossRef
  12. Telomerase reverse transcriptase moonlights: Therapeutic targets beyond telomerase
    Yoshiko Maida et al, 2015, Cancer Science CrossRef
  13. Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma
    Sylvain Ferrandon et al, 2015, Molecular Cancer CrossRef
  14. Emerging therapies for the treatment of essential thrombocythemia
    Adolfo Enrique Diaz et al, 2018, Expert Opinion on Orphan Drugs CrossRef
  15. Targeted Tumor Therapy Remixed—An Update on the Use of Small-Molecule Drugs in Combination Therapies
    Martina Gatzka, 2018, Cancers CrossRef
  16. Antisense oligonucleotides: modifications and clinical trials
    Vivek K. Sharma et al, 2014, Med. Chem. Commun. CrossRef
  17. BRD4 and Cancer: going beyond transcriptional regulation
    Benedetta Donati et al, 2018, Molecular Cancer CrossRef
  18. Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways
    Somayyeh Ghareghomi et al, 2021, Biochimie CrossRef
  19. Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials
    Nicola Relitti et al, 2020, Current Topics in Medicinal Chemistry CrossRef
  20. The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells
    Jillian E. Koziel et al, 2015, Breast Cancer Research and Treatment CrossRef
  21. Oligonucleotide inhibitors of telomerase: Prospects for anticancer therapy and diagnostics
    M. I. Zvereva et al, 2015, Biochemistry (Moscow) CrossRef
  22. Oligonucleotides Targeting Telomeres and Telomerase in Cancer
    Zachary Schrank et al, 2018, Molecules CrossRef
  23. Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review)
    Liu Yang et al, 2021, Oncology Reports CrossRef
  24. Therapeutic strategies for targeting telomerase in cancer
    Xing Chen et al, 2020, Medicinal Research Reviews CrossRef